Joel M. Kremer, MD - Safety Update of Newer Biologics in Refractory Rheumatoid Arthritis
Summary: In this activity, experts in the treatment of rheumatoid arthritis (RA) discuss updated safety data associated with the use of abatacept or rituximab in methotrexate- or TNF-antagonist-refractory RA.